Presentation ACC 2016 3-Year Results From the CoreValve US Pivotal High Risk Randomized Trial Comparing Self-Expanding Transcatheter and Surgical Aortic Valves Presenter: Michael Deeb April 03, 2016 REGISTER for free or LOG IN to view this content Aortic Valve Presentation ACC 2016 Up Next Presentation ACC 2016 Outcomes of the ABSORB Bioresorbable Vascular Scaffold in Very Small and Not Very Small Coronary Arteries: The ABSORB III randomized trial Presenter: Gregg W. Stone April 03, 2016 More slides + Presentation Three-Year Outcomes in High-Risk Patients Who Underwent Surgical or Transcatheter AVR Presenter: G. Michael Deeb April 06, 2016 Presentation Occupational Health Risks in Cardiac Catheterization Laboratory Workers Presenter: Maria Grazia Andreassi April 13, 2016 We Recommend
Presentation ACC 2016 Outcomes of the ABSORB Bioresorbable Vascular Scaffold in Very Small and Not Very Small Coronary Arteries: The ABSORB III randomized trial Presenter: Gregg W. Stone April 03, 2016
Presentation Three-Year Outcomes in High-Risk Patients Who Underwent Surgical or Transcatheter AVR Presenter: G. Michael Deeb April 06, 2016
Presentation Occupational Health Risks in Cardiac Catheterization Laboratory Workers Presenter: Maria Grazia Andreassi April 13, 2016